Art

J-GLOBAL ID：201902214586053362   Reference number：19A2663177

Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer

限局型小細胞肺癌に対する同時胸部放射線療法によるアムルビシンとシスプラチンの用量漸増試験【JST・京大機械翻訳】

Author (18)： Shimada Midori (Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan) ,  Shimada Midori (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Yamaguchi Hiroyuki (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Fukuda Minoru (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Fukuda Minoru (Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan) ,  Tomono Hiromi (Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan) ,  Honda Noritaka (Division of Respiratory Diseases, Department of Internal Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan) ,  Dotsu Yosuke (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Taniguchi Hirokazu (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Gyotoku Hiroshi (Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan) ,  Senju Hiroaki (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Takemoto Shinnosuke (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan) ,  Ikeda Takaya (Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan) ,  Nakatomi Katsumi (Department of Respiratory Medicine, Ureshino Medical Center, Ureshino, Japan) ,  Nakamura Yoichi (Department of Internal Medicine, Tochigi Cancer Center, Utsunomiya, Japan) ,  Nagashima Seiji (Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan) ,  Yamazaki Takuya (Department of Radiological Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan) ,  Mukae Hiroshi (Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan)
Material： Cancer Chemotherapy and Pharmacology
Volume： 84  Issue： 5  Page： 1059-1064  Publication year： 2019 
JST Material Number： W4134A  ISSN： 1432-0843  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： Amrubicin and cisplatin is one...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2663177&from=J-GLOBAL&jstjournalNo=W4134A") }}

Thesaurus term： *dose ,  *Radiotherapy ,  maximum tolerance ,  combination therapy ,  drug therapy ,  *small cell lung cancer ,  human ,  Death ,  Neutropenia ,  *platinum complex ,  *antitumor drug ,  *ammine complex ,  *chloro complex
Semi thesaurus term： *cisplatin ,  全生存期間 ,  生存期間 ,  進行性疾患 ,  レジメン ,  *限局型小細胞肺癌 , 【Automatic Indexing@JST】

Author keywords (4)： Amrubicin ,  Cisplatin ,  Small cell lung cancer ,  Radiotherapy

JST classification (1)： Tumors(=neoplasms)of respiratory system  (GI04000G)

Substance index (1)： Amrubicin

Terms in the title (8)： 限局型小細胞肺癌 ,  胸部 ,  放射線療法 ,  アムルビシン ,  シスプラチン ,  用量 ,  漸増 ,  試験